|
|
 Levitra
Bibliography
Below are some articles relating to Levitra (Vardenafil)
for further reading.
1: Giuliano F, Bernabe J, Alexandre L, Niewoehner U, Haning H, Bischoff E.
Pro-erectile Effect of Vardenafil: In Vitro Experiments in Rabbits and In Vivo
Comparison with Sildenafil in Rats.
Eur Urol. 2003 Dec;44(6):731-6.
14644128
2: Thadani U, Chrysant S, Mazzu A.
The effect of vardenafil, a selective PDE5 inhibitor, on ischemic threshold,
exercise tolerance, and circulatory responses during treadmill exercise in men
with stable angina pectoris.
J Am Coll Cardiol. 2003 Mar 19;41(6 Suppl B):336. No abstract available.
14637401
3: Keating GM, Scott LJ.
Vardenafil : A Review of its Use in Erectile Dysfunction.
Drugs. 2003;63(23):2673-2703.
14636086
4: Scheen AJ.
[In Process Citation]
Rev Med Liege. 2003 Sep;58(9):576-9. French.
14626653
5: Hellstrom WJ.
Vardenafil: a new approach to the treatment of erectile dysfunction.
Curr Urol Rep. 2003 Dec;4(6):479-87.
14622502
6: Francis SH, Corbin JD.
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists.
Curr Urol Rep. 2003 Dec;4(6):457-65.
14622499
7: Rosen RC, Kostis JB.
Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
Am J Cardiol. 2003 Nov 6;92(9A):9M-18M. Review.
14609619
8: Bayes M, Rabasseda X, Prous JR.
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2003 Sep;25(7):565-97.
14571286
9: Schultheiss D, Stief CG.
[In Process Citation]
Urologe A. 2003 Oct;42(10):1322-9. German.
14569380
10: Kim NN.
Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation
survey.
Int J Impot Res. 2003 Oct;15 Suppl 5:S13-9. Review.
14551572
11: [No authors listed]
Vardenafil (levitra) for erectile dysfunction.
Med Lett Drugs Ther. 2003 Sep 29;45(1166):77-8. No abstract available.
14506469
12: Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M, Padma-Nathan
H.
Safety and efficacy of vardenafil for the treatment of men with erectile
dysfunction after radical retropubic prostatectomy.
J Urol. 2003 Oct;170(4 Pt 1):1278-83.
14501741
13: Sung BJ, Yeon Hwang K, Ho Jeon Y, Lee JI, Heo YS, Hwan Kim J, Moon J, Min
Yoon J, Hyun YL, Kim E, Jin Eum S, Park SY, Lee JO, Gyu Lee T, Ro S, Myung Cho
J.
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug
molecules.
Nature. 2003 Sep 4;425(6953):98-102.
12955149
14: Josefson D.
US advertising campaign begins for alternative to sildenafil.
BMJ. 2003 Aug 30;327(7413):468. No abstract available.
12946961
15: Porst H, Young JM, Schmidt AC, Buvat J; International Vardenafil Study
Group.
Efficacy and tolerability of vardenafil for treatment of erectile dysfunction
in patient subgroups.
Urology. 2003 Sep;62(3):519-23; discussion 523-4.
12946758
16: Shabsigh R.
Hypogonadism and erectile dysfunction: the role for testosterone therapy.
Int J Impot Res. 2003 Aug;15 Suppl 4:S9-13.
12934045
17: Kuthe A.
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
Curr Opin Urol. 2003 Sep;13(5):405-10.
12917517
18: Roumeguere T, Sternon J, Schulman CC.
[Erectile dysfunction and phosphodiesterase type 5 inhibitors]
Rev Med Brux. 2003 Jun;24(3):169-75. Review. French.
12891884
19: Kloner RA, Mullin SH, Shook T, Matthews R, Mayeda G, Burstein S, Peled H,
Pollick C, Choudhary R, Rosen R, Padma-Nathan H.
Erectile dysfunction in the cardiac patient: how common and should we treat?
J Urol. 2003 Aug;170(2 Pt 2):S46-50; discussion S50. Review.
12853773
20: Mason RG.
New phosphodiesterase type 5 inhibitors in the management of erectile
dysfunction.
J R Soc Health. 2003 Jun;123(2):79-80. No abstract available.
12852189
21: Bayes M, Rabasseda X, Prous JR.
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2003 Jun;25(5):387-408.
12851663
22: Papp G, Erdei E.
[Conservative treatment of erectile dysfunction]
Orv Hetil. 2003 Jun 1;144(22):1061-6. Review. Hungarian.
12847815
23: Rosen RC, McKenna KE.
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical
outcomes.
Annu Rev Sex Res. 2002;13:36-88. Review.
12836729
24: Sperling H, Lummen G, Schneider T, Rubben H.
[New treatment options for erectile dysfunction. Pharmacologic and
nonpharmacologic options]
Herz. 2003 Jun;28(4):314-24. German.
12825147
25: Borer J, Armstrong P; Food and Drug Administration Cardiovascular and Renal
Drugs Advisory Committee.
Proceedings of the 99th meeting of the Food and Drug Administration
Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
Circulation. 2003 Jun 17;107(23):e9052. No abstract available.
12814989
26: Bayes M, Rabasseda X, Prous JR.
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2003 May;25(4):317-40.
12808477
27: Angulo J, Cuevas P, Cuevas B, Bischoff E, Saenz de Tejada I.
Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve
stimulation in female dogs.
Int J Impot Res. 2003 Apr;15(2):137-41.
12789394
28: Angulo J, Bischoff E, Gabancho S, Cuevas P, Saenz de Tejada I.
Vardenafil reverses erectile dysfunction induced by paroxetine in rats.
Int J Impot Res. 2003 Apr;15(2):90-3.
12789386
29: Bayes M, Rabasseda X, Prous JR.
Gateways to clinical trials. March 2003.
Methods Find Exp Clin Pharmacol. 2003 Mar;25(2):145-68.
12731460
30: Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, Huang YH,
Goldstein I.
Effects of medical or surgical castration on erectile function in an animal
model.
J Androl. 2003 May-Jun;24(3):381-7.
12721214
31: Junemann KP.
[How effective are PDE-5 inhibitors?]
Urologe A. 2003 Apr;42(4):553-8. Epub 2003 Mar 25. German.
12715127
32: Martin-Morales A, Rosen RC.
Effective treatment of erectile dysfunction with vardenafil.
Drugs Today (Barc). 2003 Jan;39(1):51-9. Review.
12669108
33: Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T,
Padma-Nathan H; Vardenafil Study Group.
Sustained efficacy and tolerability of vardenafil, a highly potent selective
phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of
a randomized, double-blind, 26-week placebo-controlled pivotal trial.
Urology. 2003 Apr;61(4 Suppl 1):8-14.
12657355
34: Wyllie MG.
The phosphodiesterase inhibitor 'war'.
BJU Int. 2003 Apr;91(6):573-4. Review. No abstract available.
12656917
35: Rajagopalan P, Mazzu A, Xia C, Dawkins R, Sundaresan P.
Effect of high-fat breakfast and moderate-fat evening meal on the
pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the
treatment of erectile dysfunction.
J Clin Pharmacol. 2003 Mar;43(3):260-7.
12638394
36: Carrier S.
Pharmacology of phosphodiesterase 5 inhibitors.
Can J Urol. 2003 Feb;10 Suppl 1:12-6. Review.
12625845
37: [No authors listed]
[New potency pill. Treating (vascular) bed failure]
MMW Fortschr Med. 2003 Jan 30;145(5):51. German. No abstract available.
12619215
38: Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T;
Vardenafil Diabetes Study Group.
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of
erectile dysfunction in men with diabetes: a multicenter double-blind
placebo-controlled fixed-dose study.
Diabetes Care. 2003 Mar;26(3):777-83.
12610037
39: Montorsi F, Salonia A, Deho' F, Cestari A, Guazzoni G, Rigatti P, Stief C.
Pharmacological management of erectile dysfunction.
BJU Int. 2003 Mar;91(5):446-54. Review.
12603396
40: Rodriquez Vela L, Gonzalvo Ibarra A, Pascual Regueiro D, Rioja Sanz LA.
[Erectile dysfunction]
Actas Urol Esp. 2002 Oct;26(9):667-90. Review. Spanish.
12508460
41: Vickers MA, Satyanarayana R.
Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction
in patients with diabetes mellitus.
Int J Impot Res. 2002 Dec;14(6):466-71.
12494279
42: Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA,
Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P.
The effect of vardenafil, a potent and highly selective phosphodiesterase-5
inhibitor for the treatment of erectile dysfunction, on the cardiovascular
response to exercise in patients with coronary artery disease.
J Am Coll Cardiol. 2002 Dec 4;40(11):2006-12.
12475462
43: Gresser U, Gleiter CH.
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5
inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
Eur J Med Res. 2002 Oct 29;7(10):435-46. Review.
12435622
44: Bayes M, Rabasseda X, Prous JR.
Gateways to Clinical Trials.
Methods Find Exp Clin Pharmacol. 2002 Sep;24(7):431-55. Review.
12428432
45: Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T,
Padma-Nathan H.
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety
in a randomized, double-blind, placebo-controlled trial.
J Androl. 2002 Nov-Dec;23(6):763-71. No abstract available.
12399521
46: Sarfati M, Mateo V, Baudet S, Rubio M, Fernandez C, Davi F, Binet JL, Delic
J, Merle-Beral H.
Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce
caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells.
Blood. 2003 Jan 1;101(1):265-9. Epub 2002 Jun 28.
12393651
47: Young JM.
Vardenafil.
Expert Opin Investig Drugs. 2002 Oct;11(10):1487-96. Review.
12387708
48: Vitezic D, Pelcic JM.
Erectile dysfunction: oral pharmacotherapy options.
Int J Clin Pharmacol Ther. 2002 Sep;40(9):393-403. Review.
12358156
49: Rotella DP.
Phosphodiesterase 5 inhibitors: current status and potential applications.
Nat Rev Drug Discov. 2002 Sep;1(9):674-82. Review.
12209148
50: Corbin JD, Francis SH.
Pharmacology of phosphodiesterase-5 inhibitors.
Int J Clin Pract. 2002 Jul-Aug;56(6):453-9. Review.
12166544
51: Nagai A, Kumon H.
[New medications for treatment of erectile dysfunction]
Nippon Rinsho. 2002 Jun;60 Suppl 6:461-4. Review. Japanese. No abstract
available.
12166201
52: Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewohner
U, van der Staay FJ, Blokland A, de Vente J.
Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and
vardenafil, on object recognition memory and hippocampal cyclic GMP levels in
the rat.
Neuroscience. 2002;113(2):351-61.
12127092
53: Bayes M, Rabasseda X, Prous JR.
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2002 May;24(4):217-48. Review.
12092009
54: Sommer F, Engelmann U.
Vardenafil Bayer Yakuhin.
Curr Opin Investig Drugs. 2002 Apr;3(4):607-13. Review.
12090732
55: Eardley I, Cartledge J.
Tadalafil (Cialis) for men with erectile dysfunction.
Int J Clin Pract. 2002 May;56(4):300-4.
12074215
56: Ormrod D, Easthope SE, Figgitt DP.
Vardenafil.
Drugs Aging. 2002;19(3):217-27; discussion 228-9. Review. Erratum in: Drugs
Aging 2002;19(11):886. Drugs Aging. 2003;20(2):140..
12027779
57: Choi S, O'Connell L, Min K, Kim NN, Munarriz R, Goldstein I, Bischoff E,
Traish AM.
Efficacy of vardenafil and sildenafil in facilitating penile erection in an
animal model.
J Androl. 2002 May-Jun;23(3):332-7.
12002434
58: [No authors listed]
Study shows patients taking vardenafil consistently completed sexual
intercourse.
Urol Nurs. 2001 Dec;21(6):413-4. No abstract available.
11998511
59: [No authors listed]
Coming together.
Diabetes Obes Metab. 2002 Mar;4(2):145-6. No abstract available.
11993447
60: Haning H, Niewohner U, Schenke T, Es-Sayed M, Schmidt G, Lampe T, Bischoff
E.
Imidazo[5,1-f]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors.
Bioorg Med Chem Lett. 2002 Mar 25;12(6):865-8.
11958981
61: Saenz de Tejada I, Angulo J, Cuevas P, Fernandez A, Moncada I, Allona A,
Lledo E, Korschen HG, Niewohner U, Haning H, Pages E, Bischoff E.
The phosphodiesterase inhibitory selectivity and the in vitro and in vivo
potency of the new PDE5 inhibitor vardenafil.
Int J Impot Res. 2001 Oct;13(5):282-90.
11890515
62: [No authors listed]
[Therapy of erectile dysfunction. New, highly selective PDE-5 inhibitor]
MMW Fortschr Med. 2002 Feb 14;144(7):61. German. No abstract available.
11887736
63: [No authors listed]
[Erectile dysfunction. New therapy options ante portas]
MMW Fortschr Med. 2002 Feb 14;144(7):60. German. No abstract available.
11887735
64: Pryor J.
Vardenafil: update on clinical experience.
Int J Impot Res. 2002 Feb;14 Suppl 1:S65-9. Review.
11850738
65: Brock G.
Towards optimal ED management: educational forum - II.
Can J Urol. 2001 Dec;8(6):1419-20. No abstract available.
11799971
66: Kim NN, Huang YH, Goldstein I, Bischoff E, Trais AM.
Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle
cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
Life Sci. 2001 Sep 28;69(19):2249-56.
11669467
67: Hatzichristou DG, Pescatori ES.
Current treatments and emerging therapeutic approaches in male erectile
dysfunction.
BJU Int. 2001 Oct;88 Suppl 3:11-7. Review. No abstract available.
11578273
68: Stark S, Sachse R, Liedl T, Hensen J, Rohde G, Wensing G, Horstmann R,
Schrott KM.
Vardenafil increases penile rigidity and tumescence in men with erectile
dysfunction after a single oral dose.
Eur Urol. 2001 Aug;40(2):181-8; discussion 189-90.
11528196
69: Bischoff E.
Rabbits as models for impotence research.
Int J Impot Res. 2001 Jun;13(3):146-8. Review.
11525311
70: Bischoff E, Schneider K.
A conscious-rabbit model to study vardenafil hydrochloride and other agents
that influence penile erection.
Int J Impot Res. 2001 Aug;13(4):230-5.
11494080
71: Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E,
Bandel T.
The efficacy and tolerability of vardenafil, a new, oral, selective
phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the
first at-home clinical trial.
Int J Impot Res. 2001 Aug;13(4):192-9.
11494074
72: Padma-Nathan H, Giuliano F.
Oral drug therapy for erectile dysfunction.
Urol Clin North Am. 2001 May;28(2):321-34. Review.
11402584
73: Klotz T, Sachse R, Heidrich A, Jockenhovel F, Rohde G, Wensing G, Horstmann
R, Engelmann R.
Vardenafil increases penile rigidity and tumescence in erectile dysfunction
patients: a RigiScan and pharmacokinetic study.
World J Urol. 2001 Feb;19(1):32-9.
11289568
74: Bischoff E, Niewoehner U, Haning H, Es Sayed M, Schenke T, Schlemmer KH.
The oral efficacy of vardenafil hydrochloride for inducing penile erection in a
conscious rabbit model.
J Urol. 2001 Apr;165(4):1316-8.
11257708
75: Rosen RC.
Sexual pharmacology in the 21st century.
J Gend Specif Med. 2000 Jul-Aug;3(5):45-52.
11253255
|
